The US Food and Drug Administration (FDA) has approved the first generic version of enoxaparin sodium injection, an anticoagulant used to prevent potentially fatal deep vein thrombosis.
Injectable enoxaparin often is used to prevent blood clots in patients who have had knee or hip replacement or, in some cases, abdominal surgery. Enoxaparin is in the low-molecular-weight heparin class of drugs and is used differently than heparin even though both are anticoagulants.
Voelker R. FDA Approves Generic Enoxaparin. JAMA. 2010;304(8):844. doi:10.1001/jama.2010.1195
Customize your JAMA Network experience by selecting one or more topics from the list below.